<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD08330000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P19525</UniProt_ID>
  <Seq_Length>551</Seq_Length>
  <Molecule_Weight>62094</Molecule_Weight>
  <KEGG_ID>hsa:5610</KEGG_ID>
  <Orthology_ID>K16195</Orthology_ID>
  <EBI_ID>EBI-640775</EBI_ID>
  <Function_Summary>Following activation by double-stranded RNA in the presence of ATP, the kinase becomes autophosphorylated and can catalyze the phosphorylation of the translation initiation factor EIF2S1, which leads to an inhibition of the initiation of protein synthesis. Double-stranded RNA is generated during the course of a viral infection. In addition to serine/threonine-protein kinase activity, also has tyrosine-protein kinase activity: phosphorylates CDK1 upon DNA damage. CDK1 phosphorylation triggers CDK1 polyubiquitination and subsequent proteolysis, thus leading to G2 arrest.</Function_Summary>
  <Catalytic_Mechanism>ATP + a protein = ADP + a phosphoprotein.@@ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF00035:dsrm@@PF00069:Pkinase</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>eIF-2A protein kinase 2</Alias>
      <Alias>P1/eIF-2A protein kinase</Alias>
      <Alias>Tyrosine-protein kinase EIF2AK2</Alias>
      <Alias>Protein kinase RNA-activated</Alias>
      <Alias>Eukaryotic translation initiation factor 2-alpha kinase 2</Alias>
      <Alias>PKR</Alias>
      <Alias>Interferon-inducible RNA-dependent protein kinase</Alias>
      <Alias>2.7.10.2&lt;/ecNumber</Alias>
      <Alias>p68 kinase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP +</Detail>
      <Keyword>Eukaryotic translation initiation factor 2alpha kinase activity</Keyword>
      <Ontology_ID>GO:0004694</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.</Detail>
      <Keyword>Protein tyrosine kinase activity</Keyword>
      <Ontology_ID>GO:0004713</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with double-stranded RNA.</Detail>
      <Keyword>Double-stranded RNA binding</Keyword>
      <Ontology_ID>GO:0003725</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + a non-membrane spanning protein L-tyrosine = ADP + a non-membrane spanning protein L-tyrosine phosphate.</Detail>
      <Keyword>Non-membrane spanning protein tyrosine kinase activity</Keyword>
      <Ontology_ID>GO:0004715</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Modulation of the activity of the enzyme protein phosphatase type 2A.</Detail>
      <Keyword>Protein phosphatase type 2A regulator activity</Keyword>
      <Ontology_ID>GO:0008601</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an RNA molecule or a portion thereof.</Detail>
      <Keyword>RNA binding</Keyword>
      <Ontology_ID>GO:0003723</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.</Detail>
      <Keyword>Protein serine/threonine kinase activity</Keyword>
      <Ontology_ID>GO:0004674</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>428</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>506</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>439</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process, either active or passive, by which a virus avoids the effects of the host organism's immune response. The host is defined as the larger of the organisms involved in a symbiotic interaction.</Detail>
      <Keyword>Evasion by virus of host immune response</Keyword>
      <Ontology_ID>GO:0030683</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a virus effects a change in the cellular pathways and activities of its host organism.</Detail>
      <Keyword>Modulation by virus of host cellular process</Keyword>
      <Ontology_ID>GO:0019054</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.</Detail>
      <Keyword>Response to virus</Keyword>
      <Ontology_ID>GO:0009615</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate or extent of osteoblast proliferation.</Detail>
      <Keyword>Negative regulation of osteoblast proliferation</Keyword>
      <Ontology_ID>GO:0033689</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A set of processes which all viruses follow to ensure survival; includes attachment and entry of the virus particle, decoding of genome information, translation of viral mRNA by host ribosomes, genome replication, and assembly and release of viral particles containing the genome.</Detail>
      <Keyword>Viral infectious cycle</Keyword>
      <Ontology_ID>GO:0019058</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The phosphorylation by a protein of one or more of its own amino acid residues, or residues on an identical protein.</Detail>
      <Keyword>Protein autophosphorylation</Keyword>
      <Ontology_ID>GO:0046777</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylalanine</PTM_Type>
    </PTM>
    <PTM>
      <Position>242</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>89</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>88</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>446</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>83</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>258</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>456</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>90</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>255</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>451</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MAGDLSAGFFMEELNTYRQKQGVVLKYQELPNSGPPHDRRFTFQVIIDGREFPEGEGRSKKEAKNAAAKLAVEILNKEKKAVSPLLLTTTNSSEGLSMGNYIGLINRIAQKKRLTVNYEQCASGVHGPEGFHYKCKMGQKEYSIGTGSTKQEAKQLAAKLAYLQILSEETSVKSDYLSSGSFATTCESQSNSLVTSTLASESSSEGDFSADTSEINSNSDSLNSSSLLMNGLRNNQRKAKRSLAPRFDLPDMKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC</Protein_Seq>
    <DNA_Seq>AGCAGACGAGGGCTTGTGCGAGAGGGGGCCGGGCGGCTGCAGGGAAGGCGGAGTCCAAGGGGAAAACGAAACTGAGAACCAGCTCTCCCGAAGCCGCGGGTCTCCGGCCGGCGGCGGCGGCGGCGGCGGCGGCGGCGCAGTTTCTGGAGCAAATTCAGTTTGCCTTCCTGGATTTGTAAATTGTAATGACCTCAAAACTTTAGCAGTTCTTCCATCTGACTCAGGTTTGCTTCTCTGGCGGTCTTCAGAATCAACATCCACACTTCCGTGATTATCTGCGTGCATTTTGGACAAAGCTTCCAACCAGGATACGGGAAGAAGAAATGGCTGGTGATCTTTCAGCAGGTTTCTTCATGGAGGAACTTAATACATACCGTCAGAAGCAGGGAGTAGTACTTAAATATCAAGAACTGCCTAATTCAGGACCTCCACATGATAGGAGGTTTACATTTCAAGTTATAATAGATGGAAGAGAATTTCCAGAAGGTGAAGGTAGATCAAAGAAGGAAGCAAAAAATGCCGCAGCCAAATTAGCTGTTGAGATACTTAATAAGGAAAAGAAGGCAGTTAGTCCTTTATTATTGACAACAACGAATTCTTCAGAAGGATTATCCATGGGGAATTACATAGGCCTTATCAATAGAATTGCCCAGAAGAAAAGACTAACTGTAAATTATGAACAGTGTGCATCGGGGGTGCATGGGCCAGAAGGATTTCATTATAAATGCAAAATGGGACAGAAAGAATATAGTATTGGTACAGGTTCTACTAAACAGGAAGCAAAACAATTGGCCGCTAAACTTGCATATCTTCAGATATTATCAGAAGAAACCTCAGTGAAATCTGACTACCTGTCCTCTGGTTCTTTTGCTACTACGTGTGAGTCCCAAAGCAACTCTTTAGTGACCAGCACACTCGCTTCTGAATCATCATCTGAAGGTGACTTCTCAGCAGATACATCAGAGATAAATTCTAACAGTGACAGTTTAAACAGTTCTTCGTTGCTTATGAATGGTCTCAGAAATAATCAAAGGAAGGCAAAAAGATCTTTGGCACCCAGATTTGACCTTCCTGACATGAAAGAAACAAAGTATACTGTGGACAAGAGGTTTGGCATGGATTTTAAAGAAATAGAATTAATTGGCTCAGGTGGATTTGGCCAAGTTTTCAAAGCAAAACACAGAATTGACGGAAAGACTTACGTTATTAAACGTGTTAAATATAATAACGAGAAGGCGGAGCGTGAAGTAAAAGCATTGGCAAAACTTGATCATGTAAATATTGTTCACTACAATGGCTGTTGGGATGGATTTGATTATGATCCTGAGACCAGTGATGATTCTCTTGAGAGCAGTGATTATGATCCTGAGAACAGCAAAAATAGTTCAAGGTCAAAGACTAAGTGCCTTTTCATCCAAATGGAATTCTGTGATAAAGGGACCTTGGAACAATGGATTGAAAAAAGAAGAGGCGAGAAACTAGACAAAGTTTTGGCTTTGGAACTCTTTGAACAAATAACAAAAGGGGTGGATTATATACATTCAAAAAAATTAATTCATAGAGATCTTAAGCCAAGTAATATATTCTTAGTAGATACAAAACAAGTAAAGATTGGAGACTTTGGACTTGTAACATCTCTGAAAAATGATGGAAAGCGAACAAGGAGTAAGGGAACTTTGCGATACATGAGCCCAGAACAGATTTCTTCGCAAGACTATGGAAAGGAAGTGGACCTCTACGCTTTGGGGCTAATTCTTGCTGAACTTCTTCATGTATGTGACACTGCTTTTGAAACATCAAAGTTTTTCACAGACCTACGGGATGGCATCATCTCAGATATATTTGATAAAAAAGAAAAAACTCTTCTACAGAAATTACTCTCAAAGAAACCTGAGGATCGACCTAACACATCTGAAATACTAAGGACCTTGACTGTGTGGAAGAAAAGCCCAGAGAAAAATGAACGACACACATGTTAGAGCCCTTCTGAAAAAGTATCCTGCTTCTGATATGCAGTTTTCCTTAAATTATCTAAAATCTGCTAGGGAATATCAATAGATATTTACCTTTTATTTTAATGTTTCCTTTAATTTTTTACTATTTTTACTAATCTTTCTGCAGAAACAGAAAGGTTTTCTTCTTTTTGCTTCAAAAACATTCTTACATTTTACTTTTTCCTGGCTCATCTCTTTATTCTTTTTTTTTTTTTAAAGACAGAGTCTCGCTCTGTTGCCCAGGCTGGAGTGCAATGACACAGTCTTGGCTCACTGCAACTTCTGCCTCTTGGGTTCAAGTGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGATTACAGGCATGTGCCACCCACCCAACTAATTTTTGTGTTTTTAATAAAGACAGGGTTTCACCATGTTGGCCAGGCTGGTCTCAAACTCCTGACCTCAAGTAATCCACCTGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGGATGAGCCACCGCGCCCAGCCTCATCTCTTTGTTCTAAAGATGGAAAAACCACCCCCAAATTTTCTTTTTATACTATTAATGAATCAATCAATTCATATCTATTTATTAAATTTCTACCGCTTTTAGGCCAAAAAAATGTAAGATCGTTCTCTGCCTCACATAGCTTACAAGCCAGCTGGAGAAATATGGTACTCATTAAAAAAAAAAAAAAAAGTGATGTACAACCACTTCGGAAAACAATTTGGCATTATCTAGTAAAGTTGAATCCATGTATACCCACATAGCTATCAATTCTATTCCTACATACGTGCTTACAAGAATGTCCATAAAACCCTGTTTATAATAGCCAAAAGAACAGGGAACAACCATAATGCACATCAAAAGAAGAATGGATTAAAAAAATTATATTCACACACAGGAGTACTATATAGTATTGAAAACAATTGAAGTACAGCTAAATGTAATAACGTAACACAATACAACTCTCAGAAACATAATGTTAAGCGAACAAAGCAGGTTTTCAGAAAATATATGCAGAATAATTCCATTTATATAAAGTTCCAGAGCATGCAAAACTAAATCATTTTGTATAAAAAACCCAACAAATGTGATGAGACAATAATGGGAAGGAAGGGAATGAGAAATATTAAATTCTGGATGGTGGTTATCTTTGAGGGAGGGGAATGATGTGATTGGGGAAATGGACTTTCAAAGGTAATGGTAACTTCCTTAAGCTGGATGGTAGGTCCACTAGTGTTTGCTGCATAGTTATACCTTTTATCTTAAATACATTTTGTATCTATTGTAACAACCACTTTAAAGACAACCGTGCTGTAAGGCAGTAGCTAAAAACAGAAAATAGTCCATCGGGAAGGGTAAGATGGCTTTCTGCTGAGCACAGGGCTAGAAGTGACAGCCCAGTGGGCCTTCCAACTATATGCCAGGGTGTTAGATGAGTAGAGAGGAGACCACCCAGGAAGTCTGGACAAGGGGTCTGGCATGAGCTCTGGAGAAGATATATTTGAGGAACATGGGGTATGCTAGTTTGTTGTCCTGAATTGCTGTAGAGAAGATAATTTAAATTGCATCTTAGAAGACGACCCTGAGGGTGAATTTCAACTTAGGGCAATTGTTTTAGTTTGTTTCTTATTGGTTTAAATGGATACTTGAAGCTGGATAATTTATAAGGAAAAGAGATTTATATGACTTACAGTTCTGCAGGCTGTACAAGAAACATGGCACCAGCATCTGCTTCTTCCCCGGCTGCTTCCACTCATGGTGGAAGGTGAAGGGGAGCCGGATGTGCAGAGATCATATGGCAAGAGAGGAAGCAAGAGAGCGAGGGAGAAGGTGCCAGGCTCTTTTTAAATAACCGGCTCTTGAGGGAACTAATAGATTGAGAACTCCTTGCTTCTCCTCCCCAGCACACCCCACCCCCAGGGACGGCATTAATGTATTCATGAGGGGTCTTCCCCCATGACCCAAACACCTCCCATCAGGCCCCACCTCCAACACTGGGATCAAATTTCAACATGAGATTTTGGGGGACAAACATGCAAACTATAGCAGCAACCAGCTACCATTCTAAAACTGCCATATGATTTTAGGATTTTTAAAAAGGGCCAAATTTAGGTTAAGCAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>EIF2AK2</Gene_Name>
    <Gene_Alias>PKR; PRKR</Gene_Alias>
    <Gene_ID>5610</Gene_ID>
    <Genbank_ACCN>NM_001135651</Genbank_ACCN>
    <Protein_ACCN>NP_001129123</Protein_ACCN>
    <HGNC_ID>9437</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/5610</Gene_URL>
    <UCSC_ID>uc010fac.3</UCSC_ID>
    <EMBL_ID>ENSG00000055332</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q27968</Uniprot_ID>
      <Gene_Name>DNAJC3</Gene_Name>
      <EBI_ID>EBI-640793</EBI_ID>
      <PPI_EBI_URL>EBI-640775,EBI-640793</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Herpes Simplex</Disease_Name>
      <Disease_Detail>Herpes Simplex</Disease_Detail>
      <Disease_DB>HRP006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/herpes_simplex?search=EIF2AK2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Birt-Hogg-Dube Syndrome</Disease_Name>
      <Disease_Detail>Birt-Hogg-Dube Syndrome</Disease_Detail>
      <Disease_DB>BRT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/birt_hogg_dube_syndrome?search=EIF2AK2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parainfluenza Virus Type 3</Disease_Name>
      <Disease_Detail>Parainfluenza Virus Type 3</Disease_Detail>
      <Disease_DB>PRN029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parainfluenza_virus_type_3?search=EIF2AK2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Fanconi Anemia, Complementation Group C</Disease_Name>
      <Disease_Detail>Fanconi Syndrome</Disease_Detail>
      <Disease_DB>FNC044</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/fanconi_anemia_complementation_group_c?search=EIF2AK2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hepatitis D</Disease_Name>
      <Disease_Detail>Hepatitis D</Disease_Detail>
      <Disease_DB>HPT015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hepatitis_d?search=EIF2AK2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Rift Valley Fever</Disease_Name>
      <Disease_Detail>Rift Valley Fever</Disease_Detail>
      <Disease_DB>RFT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rift_valley_fever?search=EIF2AK2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>PKR kinase domain-eIF2alpha Complex</PDB_Title>
      <PDB_ID>2A1A</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2A1A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Higher-Order Substrate Recognition of eIF2alpha by the RNA-Dependent Protein Kinase PKR.</PubMed_Title>
      <Author>Dar, A.C., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2005)122:887-900</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16179258?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PKR kinase domain- eIF2alpha- AMP-PNP complex.</PDB_Title>
      <PDB_ID>2A19</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2A19</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Higher-Order Substrate Recognition of eIF2alpha by the RNA-Dependent Protein Kinase PKR.</PubMed_Title>
      <Author>Dar, A.C., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2005)122:887-900</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16179258?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF THE DOUBLE-STRANDED RNA-BINDING DOMAIN OF THE PROTEIN KINASE PKR REVEALS THE MOLECULAR BASIS OF ITS DSRNA-MEDIATED ACTIVATION</PDB_Title>
      <PDB_ID>1QU6</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QU6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation.</PubMed_Title>
      <Author>Nanduri, S., et al.</Author>
      <Journal>EMBO J.(1998)17:5458-5465</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9736623?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05160</Pathway_ID>
      <Pathway_Title>Hepatitis C</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05164</Pathway_ID>
      <Pathway_Title>Influenza A</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05169</Pathway_ID>
      <Pathway_Title>Epstein-Barr virus infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05162</Pathway_ID>
      <Pathway_Title>Measles</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/2a19</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Dimerization</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.11.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/11/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>